| Year |
Citation |
Score |
| 2020 |
Vu NB, Le NT, Chaisuparat R, Thunyakitpisal P, Tran NM. Ameloblastic Carcinoma in a 2-Year-Old Child: A Case Report and Review of the Literature. Case Reports in Dentistry. 2020: 4072890. PMID 32774938 DOI: 10.1155/2020/4072890 |
0.326 |
|
| 2020 |
Daskalopoulos AG, Avgoustidis D, Chaisuparat R, Karanikou M, Lazaris AC, Sklavounou A, Nikitakis NG. Assessment of TLR4 and TLR9 signaling and correlation with human papillomavirus status and histopathologic parameters in oral tongue squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. PMID 32173390 DOI: 10.1016/J.Oooo.2020.01.001 |
0.349 |
|
| 2016 |
Chaisuparat R, Limpiwatana S, Kongpanitkul S, Yodsanga S, Jham BC. The Akt/mTOR pathway is activated in verrucous carcinoma of the oral cavity. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. PMID 26775690 DOI: 10.1111/Jop.12422 |
0.673 |
|
| 2013 |
Chaisuparat R, Yodsanga S, Montaner S, Jham BC. Activation of the Akt/mTOR pathway in dentigerous cysts, odontogenic keratocysts, and ameloblastomas. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 116: 336-42. PMID 23953418 DOI: 10.1016/J.Oooo.2013.06.013 |
0.692 |
|
| 2013 |
Chaisuparat R, Rojanawatsirivej S, Yodsanga S. Ribosomal protein S6 phosphorylation is associated with epithelial dysplasia and squamous cell carcinoma of the oral cavity. Pathology Oncology Research : Por. 19: 189-93. PMID 23015458 DOI: 10.1007/S12253-012-9568-Y |
0.433 |
|
| 2012 |
Scheper MA, Duarte EC, Intapa C, Zhang M, Nascimento LM, Almeida TP, Gomes AC, Song S, Chaisuparat R, Batista AC, Jham BC. Expression of midkine in ameloblastomas and its correlation with clinicopathologic parameters. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 114: 497-502. PMID 22986245 DOI: 10.1016/J.Oooo.2012.06.013 |
0.607 |
|
| 2011 |
Wen J, Nikitakis NG, Chaisuparat R, Greenwell-Wild T, Gliozzi M, Jin W, Adli A, Moutsopoulos N, Wu T, Warburton G, Wahl SM. Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma. The American Journal of Pathology. 178: 2866-78. PMID 21641406 DOI: 10.1016/J.Ajpath.2011.02.017 |
0.468 |
|
| 2011 |
Jham BC, Ma T, Hu J, Chaisuparat R, Friedman ER, Pandolfi PP, Schneider A, Sodhi A, Montaner S. Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma. Plos One. 6: e19103. PMID 21559457 DOI: 10.1371/Journal.Pone.0019103 |
0.722 |
|
| 2011 |
Almubarak H, Jones A, Chaisuparat R, Zhang M, Meiller TF, Scheper MA. Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers. Journal of Carcinogenesis. 10: 2. PMID 21297922 DOI: 10.4103/1477-3163.75723 |
0.308 |
|
| 2010 |
Scheper M, Chaisuparat R, Cullen K, Meiller T. A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis. Fibrogenesis & Tissue Repair. 3: 6. PMID 20359336 DOI: 10.1186/1755-1536-3-6 |
0.32 |
|
| 2010 |
Chaisuparat R, Scheper MA, Thunyakitpisal P. Abstract 5653: Thein vitroeffects of aloe-emodin on head and neck squamous cell carcinoma Cancer Research. 70: 5653-5653. DOI: 10.1158/1538-7445.Am10-5653 |
0.428 |
|
| 2009 |
Scheper MA, Badros A, Chaisuparat R, Cullen KJ, Meiller TF. Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. British Journal of Haematology. 144: 667-76. PMID 19036117 DOI: 10.1111/J.1365-2141.2008.07504.X |
0.372 |
|
| 2009 |
Scheper MA, Chaisuparat R, Nikitakis NG, Sauk JJ. Expression and alterations of the PTEN / AKT / mTOR pathway in ameloblastomas. Oral Diseases. 14: 561-8. PMID 18826385 DOI: 10.1111/J.1601-0825.2007.01421.X |
0.478 |
|
| 2009 |
Montaner S, Chaisuparat R, Hu J, Jham B. AKT/TSC/mTOR activation by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: novel therapeutic targets for the treatment of Kaposi's sarcoma Infectious Agents and Cancer. 4: 29. DOI: 10.1186/1750-9378-4-S2-P29 |
0.72 |
|
| 2008 |
Chaisuparat R, Hu J, Jham BC, Knight ZA, Shokat KM, Montaner S. Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma. Cancer Research. 68: 8361-8. PMID 18922908 DOI: 10.1158/0008-5472.Can-08-0878 |
0.733 |
|
| 2008 |
Scheper MA, Badros AZ, Chaisuparat R, Cullen K, Meiller TF. Role of Zoledronic Acid in the Apoptotic Cell Death of Oral Fibroblasts and Epithelial Cells: A Mechanism of Bisphosphonate-Associated Osteonecrosis Blood. 112: 5131-5131. DOI: 10.1182/Blood.V112.11.5131.5131 |
0.402 |
|
| 2007 |
Scheper MA, Nikitakis NG, Chaisuparat R, Montaner S, Sauk JJ. Sulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinoma. Neoplasia (New York, N.Y.). 9: 192-9. PMID 17401459 DOI: 10.1593/Neo.06781 |
0.701 |
|
| 2006 |
Sodhi A, Chaisuparat R, Hu J, Ramsdell AK, Manning BD, Sausville EA, Sawai ET, Molinolo A, Gutkind JS, Montaner S. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell. 10: 133-43. PMID 16904612 DOI: 10.1016/J.Ccr.2006.05.026 |
0.702 |
|
| 2006 |
Chaisuparat R, Coletti D, Kolokythas A, Ord RA, Nikitakis NG. Primary intraosseous odontogenic carcinoma arising in an odontogenic cyst or de novo: a clinicopathologic study of six new cases. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 101: 194-200. PMID 16448921 DOI: 10.1016/J.Tripleo.2005.03.037 |
0.306 |
|
| 2004 |
Thunyakitpisal PD, Chaisuparat R. Simvastatin, an HMG-CoA reductase inhibitor, reduced the expression of matrix metalloproteinase-9 (Gelatinase B) in osteoblastic cells and HT1080 fibrosarcoma cells. Journal of Pharmacological Sciences. 94: 403-9. PMID 15107580 DOI: 10.1254/Jphs.94.403 |
0.319 |
|
| Show low-probability matches. |